Delivery Order SPE2DB20D1109-SPE2DB23FN76P
Award Date 3/21/23
Potential Completion Date 3/22/23
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,873,962 milliliters of dextroamphetamine 5 milligrams per 5 milliliters, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price, non-set-aside delivery order with a ceiling value of $3,379.93 and a performance period...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,624,784 tablets of the prescription drug dextroamphetamine-amphetamine 5 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,884.44 and a period of performance through June 24, 2025. This contract is not...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,379.38 firm-fixed-price contract is for the delivery of 4,566,357,650 units of 5 mg dextroamphetamine-amphetamine tablets, which will be completed by November 7, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This contract award is for the delivery of 4,566,502,384 tablets of dextroamphetamine-amphetamine 15 mg, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The $1,658.24 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024. The contract has an ultimate completion date of November 21, 2024 and was not set aside for any specific...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of 15 milligram dextroamphetamine-amphetamine, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $2,251.46 and a completion date of May 22, 2025. This award is not a set-aside and is part of...
- This federal contract award, valued at $4,670.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,119,755 units of the prescription medication dextroamphetamine-amphetamine 5 mg tablets. The contract has a firm-fixed price and an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,243.38 firm fixed-price delivery order is for the supply of 4,568,254,602 tablets of the prescription medication dextroamphetamine-amphetamine 10 mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, solicited and awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.86 firm-fixed-price delivery order contract covers the provision of 4,566,975,300 units of dextroamphetamine-amphetamine 10 mg tablets. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide a delivery order for 4,565,519,581 units of dextroamphetamine-amphetamine 20 mg tablets. The $2,205.62 firm-fixed-price contract has an ultimate completion date of August 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 10 mg tablets of the prescription medication dextroamphetamine-amphetamine, a controlled substance used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm-fixed price of $2,714.03 and a completion date of July 2, 2025. It is not designated as a set-aside contract, indicating...